Henrik Landgren

Henrik Landgren

Company: Abbvie

Job title: Director, Scientific Precision Medicine Immunology & Fibrosis Precision Medicine


Are Combination Therapies the Not-So-Distant Future? Unlocking Lung Pathobiology to Explore Combination & Sequential Therapies for IPF 3:15 pm

Considering the interactions of mechanisms of actions and how this may affect therapeutic efficacy Navigating lung biology to illuminate discussions of sequential therapy Navigating whether this would be in combination with other anti-fibrotic therapies or specific combinations Immunogenicity issues with combining two anti-fibrotics Considering the repercussions on routes of administration Which combination strategy would be…Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.